Benzinga's Top #PreMarket Gainers

Dendreon (NASDAQ: DNDN ) soared 9.37% to $3.15 in the pre-market trading after the company posted better-than-expected Q4 results and announced its plans to make PROVENGE available in Europe. Revance Therapeutics (NASDAQ: RVNC ) surged 9.54% to $29.50 in the pre-market session after dropping 10.05% on Friday. Perion Network